Atrial fibrillation, a common heart arrhythmia, is generally treated with a standard drug warfarin. However, a study suggests a new drug might provide the same treatment, but with a lower risk of stroke and embolism.

It's not uncommon for individuals to get small blood clots in veins just beneath the skin that easily heal without treatment. However, it may put those patients at a higher risk of developing a deadly blood clot.

Most individuals have no idea whether they are at risk for a serious blood clot. A new online tool featuring simple questions patients can answer may help identify those in need of preventative treatment.

You learn you have a rare cancer located at the back of your throat. Traditional therapies might affect your ability to eat, speak and swallow. A new study shows advanced radiation therapy is effective in treating this type of cancer without harsh side effects.

Some patients with coronary blockage benefit from medicine-coated stents to prop the artery open. A new study confirms stents are safe with limited use.

"Cure" isn't a word that's used very often in the cancer field. Still, a 20-year-in-the-making breakthrough could make that word more common among oncologists .

Women may be getting an added boost of protection from heart disease. Natural hormones might explain why men have higher rates of heart disease yet post-menopausal women experience a spike in cardiovascular disease.

Blood cancers - leukemia, lymphoma and myeloma - interfere with the body's ability to make healthy blood cells. Scientists may have discovered a new way to treat these diseases in ways that offer new hope.

A medication considered the standard for preventing stroke in heart arrhythmia patients may not be as effective as an anti-clotting drug that also boasts fewer side effects.